companydata.dkcompanydata.dk

Nordic Stem Cell Clinic ApS: Financial statements 2025

CVR: 44048434

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Nordic Stem Cell Clinic ApS (CVR 44048434) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -68,935 and a net result of DKK -4,310,487 compared with DKK -264,713 the year before. Equity in the 2025 report amounted to DKK -3,471,944.

Gross Profit
DKK -68,935
Profit/Loss
DKK -4,310,487
Equity
DKK -3,471,944
Total Assets
DKK 127,096
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--69K-4.3M-3.5M0
2024--265K-265K839K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Nordic Stem Cell Clinic ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Nordic Stem Cell Clinic ApS: The 2024 annual report is outJun 25, 2025

Nordic Stem Cell Clinic ApS has published its annual report for 2024. Gross profit came to DKK -264,713, and the net result was DKK -264,713.

About Nordic Stem Cell Clinic ApS

Nordic Stem Cell Clinic ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Blue Cell Clinics ApS. The management consists of Søren Paludan Sheikh. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS, SPSheikh Holding ApS and Ulveman Invest ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,935 and a net result of DKK -4,310,487 compared with DKK -264,713 the year before. Equity in the 2025 report amounted to DKK -3,471,944.

Source: annual report 2025, Danish Business Authority

Other financial years